Exact Mass: 363.15042100000005
Exact Mass Matches: 363.15042100000005
Found 146 metabolites which its exact mass value is equals to given mass value 363.15042100000005
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Methixene hydrochloride
C20H26ClNOS (363.1423536000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent
8-Methyldihydrochelerythrine
C22H21NO4 (363.14705060000006)
8-Methyldihydrochelerythrine is found in fruits. 8-Methyldihydrochelerythrine is an alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). Alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). 8-Methyldihydrochelerythrine is found in herbs and spices and fruits.
(2S)-1-[(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
C16H21N5O5 (363.15426160000004)
N-((Tetrahydro-5-oxo-2-furanyl)carbonyl)-L-histidyl-L-prolinamide
C16H21N5O5 (363.15426160000004)
2-[[[4-(3-Benzylcyclobutyl)-1,3-thiazol-2-yl]diazenyl]methyl]phenol
C21H21N3OS (363.14052560000005)
Pglu-his-pro
C16H21N5O5 (363.15426160000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Thyrotropin-Releasing Hormone (TRH), Free Acid (TRH-OH) is a physiological metabolite of Thyrotropin-Releasing Hormone.
CAY10581
C22H21NO4 (363.14705060000006)
C21H21N3O3_8,8-Dimethyl-5a,6-dihydro-3H,5H,8H-spiro[indole-2,7-pyrrolo[1,2:4,5]pyrazino[1,2-a]azepine]-3,5,12(1H,2H)-trione
Cys Gly Gly Lys
C13H25N5O5S (363.15763200000004)
Cys Gly Lys Gly
C13H25N5O5S (363.15763200000004)
Cys Lys Gly Gly
C13H25N5O5S (363.15763200000004)
Gly Cys Gly Lys
C13H25N5O5S (363.15763200000004)
Gly Cys Lys Gly
C13H25N5O5S (363.15763200000004)
Gly Gly Cys Lys
C13H25N5O5S (363.15763200000004)
Gly Gly Lys Cys
C13H25N5O5S (363.15763200000004)
Gly Lys Cys Gly
C13H25N5O5S (363.15763200000004)
Gly Lys Gly Cys
C13H25N5O5S (363.15763200000004)
Lys Cys Gly Gly
C13H25N5O5S (363.15763200000004)
Lys Gly Cys Gly
C13H25N5O5S (363.15763200000004)
Lys Gly Gly Cys
C13H25N5O5S (363.15763200000004)
8-Methyldihydrochelerythrine
C22H21NO4 (363.14705060000006)
AMINO-(3,4-DIBENZYLOXY-PHENYL)-ACETIC ACID
C22H21NO4 (363.14705060000006)
2-(METHYLSULFANYL)[1,3]OXAZOLO[4,5-B]PYRIDINE
C22H21NO4 (363.14705060000006)
1-FMOC-4-CARBOXYMETHYLENE-PIPERIDINE
C22H21NO4 (363.14705060000006)
benzyl 2-amino-5-methoxy-4-phenylmethoxybenzoate
C22H21NO4 (363.14705060000006)
Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(4-fluorophenyl)- (9CI)
C20H18FN5O (363.14953099999997)
Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(2-fluorophenyl)- (9CI)
C20H18FN5O (363.14953099999997)
[2-(dimethylamino)-2-methylpropyl] 2-hydroxy-2,2-diphenylacetate,hydrochloride
C20H26ClNO3 (363.16011160000005)
[4-(Carbazol-9-yl)-1,1-biphenyl-4-yl]boronic acid
C24H18BNO2 (363.14305179999997)
(6,9-Diphenyl-9H-carbazol-3-yl)boronic acid
C24H18BNO2 (363.14305179999997)
Efaproxiral sodium
C20H22NNaO4 (363.14464520000007)
C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent
1-[2-(4-(Trifluoromethyl)phenyl)ethyl]-6,7-dimethoxy-3,4-dihydroisoquinoline
C20H20F3NO2 (363.14460560000003)
Ozenoxacin
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors
Thiphenamil hydrochloride
C20H26ClNOS (363.1423536000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
9-(Biphenyl-4-yl)carbazole-2-boronic acid
C24H18BNO2 (363.14305179999997)
l-d-(a-Aminoadipoyl)-l-cysteinyl-d-valine
C14H25N3O6S (363.14639900000003)
2-[4-(1-adamantyl)-N-methylsulfonylanilino]acetic acid
C19H25NO4S (363.15042100000005)
Protuboxepin B
An organic heterotricyclic compound that is 10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione substituted by a benzyl group at position 8 and an isopropyl group at position 11. It has been isolated from Aspergillus species.
2-[(4-amino-5-cyclohexyl-1,2,4-triazol-3-yl)thio]-N-(3-fluoro-4-methylphenyl)acetamide
(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime
C20H18FN5O (363.14953099999997)
(2S)-1-[(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
C16H21N5O5 (363.15426160000004)
3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Phe-OH
C17H21N3O6 (363.14302860000004)
(1R,2R,5S,8S,9S,10R,11R,12R,13S)-5,12,13-trihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate
3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanyl-L-phenylalanine
C17H21N3O6 (363.14302860000004)
6-(1,3-benzodioxol-5-yl)-N-(3-oxanylmethyl)-4-quinazolinamine
(9S,11R)-12,12-dimethylspiro[1,7-diazatricyclo[7.5.0.03,7]tetradeca-3,13-diene-11,2-1H-indole]-2,3,8-trione
phe-FMDP
C17H21N3O6 (363.14302860000004)
A dipeptide composed of 3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine and L-phenylalanine joined by peptide linkages.
2,4,5-trimethoxy-N-(2-phenylphenyl)benzamide
C22H21NO4 (363.14705060000006)
N-[(E)-(5-Morpholin-4-ylthiophen-2-yl)methylideneamino]-N-phenylaniline
C21H21N3OS (363.14052560000005)
N-[[(2S)-3beta-(Ethoxycarbonyl)aziridine-2alpha-yl]carbonyl]-Gly-Gly-OBzl
C17H21N3O6 (363.14302860000004)
6-(1,3-benzodioxol-5-yl)-N-(2-oxanylmethyl)-4-quinazolinamine
hydron;1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine;chloride;hydrate
C20H26ClNOS (363.1423536000001)
[(1-amino-2-naphthalen-1-ylethylidene)amino] N-(2-ethoxyphenyl)carbamate
3-(4-Morpholinyl)-2-phenyl-1-[4-(trifluoromethyl)phenyl]-1-propanone
C20H20F3NO2 (363.14460560000003)
E1231
E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1]. E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1].
9-hydroxy-4-methoxy-10-methyl-11-(3-methylbut-2-en-1-yl)furo[3,2-b]acridin-5-one
C22H21NO4 (363.14705060000006)
2-hydroxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecan]-3'-ene-2',8'-dione
(2s,4s,5s,6s)-4,5-dihydroxy-6-[3-(c-hydroxycarbonimidoylmethyl)-4-methoxyindol-1-yl]oxane-2-carboximidic acid
C17H21N3O6 (363.14302860000004)
1-[(12s)-18-acetyl-13-methyl-5,7-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁸.0¹⁶,²⁰]icosa-1(19),2,4(8),9,16(20),17-hexaen-19-yl]ethanone
C22H21NO4 (363.14705060000006)
(2s)-2-amino-5-{[(1r)-1-{[(1r)-1-carboxy-2-methylpropyl]-c-hydroxycarbonimidoyl}-2-sulfanylethyl]-c-hydroxycarbonimidoyl}pentanoic acid
C14H25N3O6S (363.14639900000003)
3-benzyl-1-hydroxy-4-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}pyrrole-2,5-dione
C22H21NO4 (363.14705060000006)
(2s)-2-({hydroxy[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)-6-[(hydroxymethylidene)amino]hexanoic acid
C17H21N3O6 (363.14302860000004)